trial · primary record
LAmB B
Histoplasmosis
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 664 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Mortality at 2 weeks |
| Registry ID | NCT07261150 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:50.934Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07261150
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.